Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “HIV”

PrEPwise Pilot Among Black Women in Eastern VirginiaNot Yet Recruiting
NCT07398482NAUpdated Feb 11, 2026
Sponsor: Boston University
HIV Infections · Sexually Transmitted Infection
United States
Evaluating Quality of Life in Patients With AIDS-Associated Kaposi Sarcoma Treated With Bleomycin and VincristineCompleted
NCT03596918N/AUpdated Feb 11, 2026
Sponsor: AIDS Malignancy Consortium
AIDS-Related Kaposi Sarcoma · Human Immunodeficiency Virus 1 Positive
Tanzania
Optimal Intervention to Full Viral Suppression: Text Me, Alexis!Terminated
NCT06408350NAUpdated Feb 11, 2026
Sponsor: Friends Research Institute, Inc.
HIV
United States
Developing Rectal USPE Measures for Suppositories (Project DRUM-S)Completed
NCT02744261NAUpdated Feb 10, 2026
Sponsor: The Miriam Hospital
Microbicide Delivery System Perceptibility and Acceptability
United States
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat ServicesRecruiting
NCT06128304NAUpdated Feb 10, 2026
Sponsor: University of California, San Diego
HIV · Cervical Cancer
United States, Nigeria
HOTSPOT Study: Implement and Evaluate the PrEP (Pre-exposure Prophylaxis) Implementation StrategyRecruiting
NCT06919419NAUpdated Feb 10, 2026
Sponsor: University of Texas Southwestern Medical Center
PrEP · HIV · Incarceration
United States
A Study Evaluating Implementation Strategies for the Delivery of APRETUDE for Black cis-and Transgender Women in United States EHE TerritoriesCompleted
NCT05514509Phase 4Updated Feb 9, 2026
Sponsor: ViiV Healthcare
HIV Infections
United States
Effectiveness of an Integrated Treatment to Address Smoking Cessation and Anxiety/ Depression in People Living With HIVCompleted
NCT03904186NAUpdated Feb 9, 2026
Sponsor: Massachusetts General Hospital
Human Immunodeficiency Virus · Smoking Cessation · Smoking, Cigarette · Smoking
United States
Safety, Tolerability, and Immunogenicity of ALFQ in a HIV Vaccine Containing A244 and B.65321 in Healthy AdultsCompleted
NCT05423418Phase 1Updated Feb 9, 2026
Sponsor: U.S. Army Medical Research and Development Command
Human Immunodeficiency Virus (HIV) · AIDS Virus
United States
Pilot Testing a Behavioral Intervention to Incorporate Advances in HIV Prevention for Black Young MSM in AlabamaCompleted
NCT03680729NAUpdated Feb 9, 2026
Sponsor: Florida State University
HIV/AIDS
United States
Automated Video-Assisted Smoking Treatment for People Living With HIVActive Not Recruiting
NCT05014282NAUpdated Feb 9, 2026
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Smoking Cessation
United States
Addiction, HIV and Tuberculosis in Malaysian Criminal Justice SettingsCompleted
NCT03089983NAUpdated Feb 9, 2026
Sponsor: Yale University
Opioid Dependence · Addiction · HIV/AIDS · Tuberculosis
Malaysia
Building on Needle Exchange to Optimize Prevention & TreatmentCompleted
NCT03567174NAUpdated Feb 9, 2026
Sponsor: Johns Hopkins University
Intravenous Drug Usage · HIV/AIDS
United States
A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Two Different Formulations of Long-acting Cabotegravir in Healthy Adult ParticipantsCompleted
NCT06033547Phase 1Updated Feb 6, 2026
Sponsor: ViiV Healthcare
HIV Infections
United States
Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)Recruiting
NCT05136703NAUpdated Feb 6, 2026
Sponsor: Florida International University
Depression · HIV-1-infection · Inflammation
United States
Mobile Phone Messaging to Improve Reproductive Health for Women Living With HIV in Kenya (Mobile WACh Empower)Active Not Recruiting
NCT05285670NAUpdated Feb 5, 2026
Sponsor: University of Washington
Hiv · Contraception · Fertility Issues
Kenya
Dolutegravir Study in HIV-1 Participants Completing IMPAACT Studies P1093 and P2019Completed
NCT03016533Phase 3Updated Feb 5, 2026
Sponsor: ViiV Healthcare
HIV Infections
United States, Botswana, Brazil, South Africa, Tanzania +2 more
A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIVRecruiting
NCT05495906Phase 4Updated Feb 5, 2026
Sponsor: University of British Columbia
HPV · Human Papilloma Virus · Human Immunodeficiency Virus
Canada
Kaposi Sarcoma Chemotherapy and Research (KS-CARE)Active Not Recruiting
NCT06480773N/AUpdated Feb 5, 2026
Sponsor: UNC Lineberger Comprehensive Cancer Center
Kaposi Sarcoma · HIV
Malawi, South Africa
Integrating Vaccination Into Hospital Care Pathways for Vulnerable PatientsNot Yet Recruiting
NCT07391046N/AUpdated Feb 5, 2026
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Chronic Disease · Immunocompromised · HIV Infection · Chronic Kidney Disease
Safety and Immunogenicity of V116 in Adults Living With Human Immunodeficiency Virus (HIV) (V116-007, STRIDE-7)Completed
NCT05393037Phase 3Updated Feb 5, 2026
Sponsor: Merck Sharp & Dohme LLC
Pneumococcal Disease
United States, Belgium, Chile, France, South Africa +1 more
MAGIA H3S Point of Care Test Performance for HIV, HBV, HCV, and Syphilis Screening in Pregnant Women in DR CongoNot Yet Recruiting
NCT07388979N/AUpdated Feb 5, 2026
Sponsor: Gardiens de Vies
HIV - Human Immunodeficiency Virus · HBV (Hepatitis B Virus) · Hepatitis C Virus (HCV) · Syphilis
Developing Rectal USPE MeasuresCompleted
NCT02102867NAUpdated Feb 5, 2026
Sponsor: The Miriam Hospital
Microbicide Delivery System Perceptibility and Acceptability
United States
Peer-led Dynamic Choice HIV Prevention for Women: The Peer-led DCP Pilot StudyRecruiting
NCT07298785NAUpdated Feb 5, 2026
Sponsor: University of California, San Francisco
HIV/AIDS
Uganda
ALIGN: A Non-randomised Study Delivering Injectable Lenacapavir for HIV Prevention Within a Pre-exposure Prophylaxis (PrEP) Choice Context in Cape Town, South Africa.Not Yet Recruiting
NCT07390409N/AUpdated Feb 5, 2026
Sponsor: Desmond Tutu HIV Foundation
HIV
South Africa

Previous page Next page